Emi Tanaka

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Escherichia Coli

Respiratory Tract

Top Venues

Microbial drug resistance (Larchmont, N.Y.)

The Journal of antimicrobial chemotherapy

Microbiology spectrum

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Takeaki Wajima, Takashi Sugawara, Emi Tanaka, Kei-Ichi Uchiya
Molecular characterization of a novel putative pathogen, Streptococcus nakanoensis sp. nov., isolated from sputum culture. Microbiology spectrum (2024)
Takeaki Wajima, Naoki Hara, Emi Tanaka, Atsuko Shirai, Kei-Ichi Uchiya
Emergence of Quinolone Low-Susceptible Haemophilus influenzae Harboring the Mutated Quinolone Targeting Gene of Haemophilus haemolyticus . Microbial drug resistance (Larchmont, N.Y.) 30 (8) (2024)
Takeaki Wajima, Naoki Hara, Emi Tanaka, Atsuko Shirai, Kei-Ichi Uchiya
Emergence of Quinolone Low-Susceptible Haemophilus influenzae Harboring the Mutated Quinolone Targeting Gene of Haemophilus haemolyticus . Microbial drug resistance (Larchmont, N.Y.) (2024)
Emi Tanaka, Takeaki Wajima, Hidemasa Nakaminami, Kei-Ichi Uchiya
Contribution of amino acid substitutions in ParE to quinolone resistance in Haemophilus haemolyticus revealed through a horizontal transfer assay using Haemophilus influenzae. The Journal of antimicrobial chemotherapy (2023)
Emi Tanaka, Takeaki Wajima, Hidemasa Nakaminami, Kei-Ichi Uchiya
Alternative quinolone-resistance pathway caused by simultaneous horizontal gene transfer in Haemophilus influenzae. The Journal of antimicrobial chemotherapy 77 (12) (2022)
Emi Tanaka, Takeaki Wajima, Kei-Ichi Uchiya, Hidemasa Nakaminami
Quinolone Resistance Is Transferred Horizontally via Uptake Signal Sequence Recognition in Haemophilus influenzae. Antimicrobial agents and chemotherapy 66 (2) (2021)